Mercer Global Advisors
APYX icon

Mercer Global Advisors’s Apyx Medical APYX Stock Holding History

Mercer Global Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Buy
+4,860
New +$19.3K ﹤0.01% 4776

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's APYX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Apyx Medical (APYX) in Q2 2026: 4,860 shares worth $21.8K. The stake represents ﹤0.01% of the portfolio and ranks #4776 among its holdings.

55 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Mercer Global Advisors held 4,860 shares of Apyx Medical worth $21.8K as of Q2 2026.
  • Apyx Medical was a new Mercer Global Advisors position in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4776 holding.
  • 55 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.